Abstract:Gestational diabetes mellitus (GDM) “program” an elevated risk of metabolic syndrome in the offspring. Epigenetic alterations are a suspected mechanism. GDM has been associated with placental DNA methylation changes in some epigenome-wide association studies. It remains unclear which genes or pathways are affected, and whether any placental differential gene methylations are correlated to fetal growth or circulating metabolic health biomarkers. In an epigenome-wide association study using the Infinium MethylationEPIC Beadchip, we sought to identify genome-wide placental differentially methylated genes and enriched pathways in GDM, and to assess the correlations with fetal growth and metabolic health biomarkers in cord blood. The study samples were 30 pairs of term placentas in GDM vs. euglycemic pregnancies (controls) matched by infant sex and gestational age at delivery in the Shanghai Birth Cohort. Cord blood metabolic health biomarkers included insulin, C-peptide, proinsulin, IGF-I, IGF-II, leptin and adiponectin. Adjusting for maternal age, pre-pregnancy BMI, parity, mode of delivery and placental cell type heterogeneity, 256 differentially methylated positions (DMPs,130 hypermethylated and 126 hypomethylated) were detected between GDM and control groups accounting for multiple tests with false discovery rate <0.05 and beta-value difference >0.05. WSCD2 was identified as a differentially methylated gene in both site- and region-level analyses. We validated 7 hypermethylated (CYP1A2, GFRA1, HDAC4, LIMS2, NAV3, PAX6, UPK1B) and 10 hypomethylated (DPP10, CPLX1, CSMD2, GPR133, NRXN1, PCSK9, PENK, PRDM16, PTPRN2, TNXB) genes reported in previous epigenome-wide association studies. We did not find any enriched pathway accounting for multiple tests. DMPs in 11 genes (CYP2D7P1, PCDHB15, ERG, SIRPB1, DKK2, RAPGEF5, CACNA2D4, PCSK9, TSNARE1, CADM2, KCNAB2) were correlated with birth weight (z score) accounting for multiple tests. There were no significant correlations between placental gene methylations and cord blood biomarkers. In conclusions, GDM was associated with DNA methylation changes in a number of placental genes, but these placental gene methylations were uncorrelated to the observed metabolic health biomarkers (fetal growth factors, leptin and adiponectin) in cord blood. We validated 17 differentially methylated placental genes in GDM, and identified 11 differentially methylated genes relevant to fetal growth.

Genetic Control of Fetal Placental Genomics Contributes to Development of Health and Disease

Placental Genomics Mediates Genetic Associations with Complex Health Traits and Disease

Expression quantitative trait loci (eQTLs) in human placentas suggest developmental origins of complex diseases

Genetic Regulation of the Placental Transcriptome Underlies Birth Weight and Risk of Childhood Obesity

Genome-wide identification of transcriptional enhancers During human placental development and association with function, differentiation, and disease

Whole-transcriptome analysis delineates the human placenta gene network and its associations with fetal growth

Genome-wide Association Study of Placental Weight Identifies Distinct and Shared Genetic Influences Between Placental and Fetal Growth.

Placental Micrornas Relate to Early Childhood Growth Trajectories.

Placental multi-omics integration identifies candidate functional genes for birthweight

Placental Gene Transcript Proportions Are Altered in the Presence of in Utero Arsenic and Cadmium Exposures, Genetic Variants, and Birth Weight Differences.

Epigenetic Regulation and Related Diseases During Placental Development.

Genome-wide Placental DNA Methylations in Fetal Overgrowth and Associations with Leptin, Adiponectin and Fetal Growth Factors

Human Placental Cytotrophoblast Epigenome Dynamics over Gestation and Alterations in Placental Disease.

Maternal Pre-Pregnancy Obesity Is Associated with Altered Placental Transcriptome

Prenatal Trace Metal Exposures and Genetic Variants Inform Birth Weight-related Placental Isoform Expression

Genetically-predicted placental gene expression is associated with birthweight and adult body mass index

Deciphering the Epigenetic Landscape: Placental Development and Its Role in Pregnancy Outcomes

Genome-Wide Placental Gene Methylations in Gestational Diabetes Mellitus, Fetal Growth and Metabolic Health Biomarkers in Cord Blood

A Multiomics, Spatiotemporal, and Single Cell Atlas for Mapping Cell-Type-Specific Dysregulation at the Maternal-Fetal Interface

LAT1-dependent placental methionine uptake is a key player in fetal programming of metabolic disease

A combination analysis based on bioinformatics tools reveals new signature genes related to maternal obesity and fetal programming